Trials / Unknown
UnknownNCT06208930
The Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Digestive Diseases and Non-digestive System Diseases Associated With Gastrointestinal Symptoms in the Gastrointestinal Tract.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10,000 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The exploration of the safety and efficacy of fecal microbiota transplantation in the treatment of non-digestive system diseases associated with gastrointestinal symptoms in the gastrointestinal tract, while also investigating the impact of fecal microbiota transplantation on the intestinal system, and assessing the improvement of symptoms in other systems.Simultaneously optimizing the conditions during the FMT process, identifying the most effective treatment methods to enhance the therapeutic outcomes of FMT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Fecal microbiota transplantation | Fecal microbiota transplantation (FMT) is a method for treating imbalances in the intestinal microbiota. Its basic principle involves extracting a portion of feces from a healthy individual that contains a diverse population of beneficial bacteria, processing it, and transplanting it into the digestive system of the recipient to restore a balanced intestinal microbiota. |
Timeline
- Start date
- 2018-01-10
- Primary completion
- 2025-12-10
- Completion
- 2025-12-10
- First posted
- 2024-01-17
- Last updated
- 2024-01-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06208930. Inclusion in this directory is not an endorsement.